Clinical Trials Logo

Cancer Cachexia clinical trials

View clinical trials related to Cancer Cachexia.

Filter by:

NCT ID: NCT00378131 Completed - Cancer Cachexia Clinical Trials

Placebo Controlled, Randomized Safety and Efficacy Study of RC-1291 in Cancer Anorexia/Cachexia

Start date: September 2006
Phase: Phase 2
Study type: Interventional

Activation of Ghrelin receptors have been demonstrated to stimulate appetite. RC-1291 HCl, by virtue of its ghrelin like activity and Growth Hormone releasing effects may have a dual role in the reversal of cancer induced anorexia and cachexia. This placebo controlled study will evaluate the safety and efficacy of RC-1291 HCl in cancer patients with cachexia.

NCT ID: NCT00329615 Completed - Cancer Cachexia Clinical Trials

Insulin Treatment in Cancer Cachexia

Start date: January 2000
Phase: Phase 4
Study type: Interventional

The study is designed to evaluate whether daily insulin treatment to weight losing cancer patients attenuates progression of cancer cachexia and improves metabolism.

NCT ID: NCT00267358 Completed - Cancer Cachexia Clinical Trials

Placebo Controlled, Randomized Safety and Efficacy Study of RC-1291 in Cancer Anorexia/Cachexia.

Start date: November 2005
Phase: Phase 2
Study type: Interventional

Anorexia and cachexia are devastating complications in late-stage cancer patients and is strongly associated with mortality in these patients. Activation of Ghrelin receptors have been demonstrated to stimulate appetite. RC-1291 HCl, by virtue of its ghrelin like activity and Growth Hormone releasing effects may have a dual role in the reversal of cancer induced anorexia and cachexia. This placebo controlled study will evaluate the safety and efficacy of RC-1291 HCl in cancer patients with anorexia and cachexia.

NCT ID: NCT00219817 Completed - Cancer Cachexia Clinical Trials

Safety and Efficacy of RC-1291 HCl in Patients With Cancer Related Anorexia and Weight Loss

Start date: June 2005
Phase: Phase 2
Study type: Interventional

Anorexia and weight loss are devastating complications in late-stage cancer patients and is strongly associated with mortality in these patients. Activation of Ghrelin receptors have been demonstrated to stimulate appetite. RC-1291 HCl, by virtue of its ghrelin like activity and Growth Hormone releasing effects may have a dual role in the reversal of cancer induced anorexia and weight loss. This study will test the safety and efficacy of RC-1291 in the treatment of cancer patients with anorexia and weight loss.

NCT ID: NCT00094562 Completed - Cancer Clinical Trials

A Fish Oil Supplement to Maintain Body Weight in Patients With Disease-Related Weight Loss

Start date: June 2004
Phase: Phase 2
Study type: Interventional

The purpose of this study is to evaluate the safety and effectiveness of fish oil supplements in maintaining weight in people with disease-related weight loss and/or cachexia.